# Escalier Biosciences B.V.: Form D filing

Escalier Biosciences B.V., a biotechnology company in Nijmegen, Netherlands, filed a Form D with the SEC in 2017. The latest, on March 20, 2017, reports $3.5 million sold of a $15.5 million offering to 5 investors.

Find out what Escalier Biosciences B.V. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Escalier%20Biosciences%20B.V.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Escalier%20Biosciences%20B.V.&page=%2Fdata%2Fform-d%2Fcompany%2Fescalier-biosciences-b-v-1701386)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Escalier%20Biosciences%20B.V.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Escalier%20Biosciences%20B.V.&page=%2Fdata%2Fform-d%2Fcompany%2Fescalier-biosciences-b-v-1701386)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: TRANSISTORWEG 5J, Nijmegen, Netherlands, 6534
- Phone: (858) 945-2393
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Netherlands
- Year incorporated: 2016
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1701386

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 20, 2017 | New notice | $15,500,000 | $3,500,000 | $12,000,000 | 5 | Feb 28, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1701386/000170138617000001/0001701386-17-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Christopher Krueger | Executive Officer |  |
| Somasundaram Subramaniam | Director |  |
| E.C.M. van Wezel | Director |  |
| Raju Mohan | Director |  |

[Every Form D from the week of Mar 20, 2017](https://specstream.ai/data/form-d/week/2017-03-20) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Escalier Biosciences B.V. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).